(Q41701305)

English

Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial

scientific article published on 14 October 2014

Statements

Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial (English)
Shizuka Kaneko
Francis Chow
Dong Seop Choi
Shinji Taneda
Koichi Hirao
Yongsoo Park
Thomas Hasseriis Andersen
Mari-Anne Gall
Jens Sandahl Christiansen
BOOST: Intensify All Trial Investigators
14 October 2014
139-147

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit